Khelin Aiken supports life sciences companies as they develop innovative products and bring them to market, with particular focus on therapeutic product development plans and marketing applications for prescription drugs, including therapeutic biologics and generics. She also advises on policies related to over-the-counter (OTC) drugs. Prior to joining McDermott, Khelin served as regulatory counsel at the Food and Drug Administration (FDA) in the Center for Drug Evaluation and Research, first in the Office of Regulatory Policy, and most recently in the Office of New Drugs with the Therapeutic Biologics and Biosimilars Staff.

Show More


The George Washington University Law School, JD, 2010
Hampton University, BS, magna cum laude, 2007

District of Columbia

Khelin N. Aiken

Insights & Events / Media

Podcasts / June 26, 2019

Washington, D.C. / Speaking Engagements / April 12, 2019

Cambridge, MA / McDermott Event / March 20, 2019